Obeticholic acid as a second-line treatment for low phospholipid-associated cholelithiasis syndrome.

Pierre-Antoine Soret,Sara Lemoinne,Maxime Mallet,Karima Ben Belkacem,Olivier Chazouillères,Christophe Corpechot

Alimentary pharmacology & therapeutics（2023）

引用 0|浏览0

暂无评分

摘要

These preliminary observations suggest that OCA may have the potential to effectively treat LPAC syndrome in patients with inadequate response or intolerance to UDCA. Larger studies are needed to confirm these data.

查看译文

关键词

FXR, LPAC, OCA, UDCA

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要